The Toronto-Dominion Bank
TD
Royal Bank of Canada
RY
Canadian Imperial Bank of Commerce
CM
Bank of Nova Scotia
BNS
Bank of Montreal
BMO
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.